Regentis Biomaterials (RGNT) P/E (2025 - 2026)
Regentis Biomaterials (RGNT) P/E from Dec 31, 2025 to Jul 21, 2026. The TTM Regentis Biomaterials (RGNT) P/E is -0.39. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Regentis Biomaterials (RGNT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.39 | -69.73% |
| 2025 | -1.28 | N/A |
Comparison Regentis Biomaterials (RGNT) P/E with competitors
Regentis Biomaterials (RGNT) P/E is -0.39.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -157.85% |
| EMBC | Embecta Corp | 1.69 | -536.71% |
| SOLV | Solventum Corp | 9.49 | -2552.49% |
| ZJYL | Jin Medical International Ltd | 12.75 | -3393.46% |
| PDEX | Pro-Dex Inc (co) | 15.22 | -4032.30% |
| RMD | Resmed Inc | 19.04 | -5020.78% |
| UTMD | Utah Medical Products Inc | 20.76 | -5463.82% |
| ATR | Aptargroup Inc | 21.65 | -5693.13% |
| ALGN | Align Technology Inc | 30.29 | -7926.65% |
| HOLX | Hologic Inc | 30.86 | -8074.54% |
| MMSI | Merit Medical Systems Inc | 31.15 | -8147.43% |
| STVN | Stevanato Group Spa | 31.25 | -8175.33% |
| LMAT | Lemaitre Vascular Inc | 36.34 | -9489.52% |
| ALC | Alcon Inc | 41.51 | -10826.47% |
| ISRG | Intuitive Surgical Inc | 46.43 | -12095.72% |
| BDX | Becton Dickinson & Company | 46.93 | -12226.10% |
| WST | West Pharmaceutical Services Inc | 47.41 | -12349.01% |
| NEPH | Nephros Inc | 50.00 | -13017.90% |
| COO | Cooper Companies Inc | 58.98 | -15338.65% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | -16170.83% |
| NVST | Envista Holdings Corp | 64.66 | -16807.63% |
| BAX | Baxter International Inc | 72.66 | -18872.68% |
| ICUI | ICU Medical Inc | 84.82 | -22015.61% |
| RGEN | Repligen Corp | 162.20 | -42007.87% |
| WRBY | Warby Parker Inc - Class A | 318.30 | -82340.97% |